INSIGHTS ON CLINICAL TRIAL PARTNERING

• PCI Capacity Update July 2025: Small Molecule Drug Product/Finished Dosage Form

  Dr. Rebecca Coutts highlights PCI’s high potent oral solid dose (OSD) and oral liquid capabilities, focusing on site expertise, specialized infrastructure, and handling of complex molecules.

• How Are Therapeutic Radiopharmaceuticals Advancing Precision Oncology?

  By directing radioactive isotopes straight to diseased tissue, these agents deliver potent, localized treatment while sparing healthy cells — a major leap forward for patients with metastatic or treatment-resistant cancers.

• Shifting The Approach: 4 Tactics For ICH E6(R3) Implementation

  In addition to codifying some best practices, R3 recommends that sponsors adopt an approach to identifying and managing areas of risk to mitigate potential issues and enhance overall success.

• Meeting Our Customers Real-World Data Needs

  Learn how Citeline generates insights from data and uses those findings to create not only dynamic dashboards but also ongoing patient recruitment programs.

• Navigating The Unique Attributes Of Psychedelic Drug Development

  1/22/2024

  Join our panel of experts for an in-depth review of the FDA's guidance on psychedelic drug development, exploring necessary methodological adaptations for safety, pharmacology, and efficacy.

• Reducing Time To First-In-Human Trials With Robotic SFF Services

  6/21/2024

  Discover how robotic gloveless isolator sterile fill-finish (SFF) systems can accelerate early-phase drug development, ensuring enhanced sterility and streamlined processes for biopharma innovation.

• The Rescue Option: Course Correcting Struggling Clinical Trials

  4/14/2025

  The willingness to seek expert support from Rescue CROs when clinical trials face critical challenges is not a sign of weakness but a demonstration of accountability and commitment to excellence.

• Canadian CTA Frequently Asked Questions

  2/20/2024

  This FAQ list offers clarity on pivotal aspects of your drug development journey, ensuring studies in Canada pave the way for U.S. FDA and EMA submissions.

• Bringing Clinical Trials To Everyone's Backyard

  1/10/2025

  Learn how bringing clinical trials to any community around the world is not only possible but also increases patient access and reach and improves recruitment and retention.